Trial to Assess the Efficacy of EMPAgliflozin and Personalized Dietary Counseling for Kidney STONE Prevention

NCT06653738 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

380

Enrollment

OTHER

Sponsor class

Conditions

Kidney Stone
Nephrolithiasis
Dietary Exposure

Interventions

DRUG: Empagliflozin 25 MG
DRUG: Placebo
BEHAVIORAL: Personalized dietary counseling
BEHAVIORAL: Generic dietary counseling

Sponsor

Insel Gruppe AG, University Hospital Bern